What is Hexarelin?
Hexarelin is a hexapeptide derived from GHRP-6 that releases growth hormone very strongly via the ghrelin receptor – in humans more strongly than GHRH. It was developed by an Italian manufacturer.
How well studied is Hexarelin?
Hexarelin reached phase II trials for growth hormone deficiency and heart failure but was never fully developed or approved. Human data are limited to small studies of GH release; with continuous use the effect partly wears off (tolerance).
What side effects and risks does Hexarelin have?
Besides GH it also mildly raises prolactin, ACTH and cortisol. Via GH/IGF-1, fluid retention, joint pain and rising blood sugar are possible. Long-term safety is unknown; grey-market products are untested.
Is Hexarelin approved in Germany?
In short: no. Not approved as a medicine anywhere. Prohibited in sport (WADA S2, GH-releasing peptides); may fall under the German AntiDopG. High quality and counterfeit risk.
Sources
Note: We deliberately do not list any doses here. For approved medicines, your doctor sets the dose; for unapproved substances there is no reliable information.